Toxic liver disease with chronic active hepatitis
ICD-10 K71.5 is a used to indicate a diagnosis of toxic liver disease with chronic active hepatitis.
Toxic liver disease with chronic active hepatitis (K71.5) is characterized by ongoing inflammation of the liver due to exposure to hepatotoxic substances, such as drugs, alcohol, or environmental toxins. Clinically, patients may present with symptoms including fatigue, jaundice, abdominal pain, and elevated liver enzymes. The liver, a vital organ in the digestive system, plays a crucial role in metabolism, detoxification, and bile production. Chronic active hepatitis indicates a prolonged inflammatory process that can lead to fibrosis and potentially progress to cirrhosis or liver failure if not managed appropriately. Diagnostic considerations include a thorough patient history to identify potential toxic exposures, serological tests to assess liver function, and imaging studies to evaluate liver structure. Liver biopsy may be necessary to confirm the diagnosis and assess the degree of inflammation and fibrosis. Early detection and intervention are critical to prevent further liver damage and improve patient outcomes.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K71.5 covers chronic active hepatitis resulting from toxic liver disease, which may include conditions caused by drug-induced liver injury, alcohol-related liver disease, and exposure to environmental toxins. Diagnostic criteria typically involve evidence of chronic inflammation and liver dysfunction.
K71.5 should be used when there is clear documentation of chronic active hepatitis due to toxic exposure, distinguishing it from acute conditions or other liver diseases that may have different underlying causes.
Documentation should include a detailed patient history of exposure to hepatotoxic agents, laboratory results indicating liver function tests, imaging studies, and any biopsy results that confirm chronic active hepatitis.
